✦ LIBER ✦

Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada

✍ Scribed by Chau, D.; Becker, D. L.; Coombes, M. E.; Ioannidis, G.; Adachi, J. D.; Goeree, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of Denosumab for the

✍ B. Jönsson; O. Ström; J. A. Eisman; A. Papaioannou; E. S. Siris; A. Tosteson; J. 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 336 KB

PMS44 Cost-Effectiveness of Denosumab in

✍ A. Davies; J. Compston; S. Ferguson; E. McClosky; A. Shearer; A. Taylor 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Comment on: cost-effectiveness of denosu

✍ B. Jönsson, O. Ström, J. A. Eisman, A. Papaioannou, E. S. Siris, A. Tosteson, J. 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 166 KB

Cost–effectiveness of denosumab in the t

✍ Hiligsmann, Mickaël; Boonen, Annelies; Dirksen, Carmen D; Sedrine, Wafa Ben; Reg 📂 Article 📅 2013 🏛 Expert Reviews 🌐 English ⚖ 999 KB

Denosumab for the treatment of postmenop

✍ Lewiecki, E Michael 📂 Article 📅 2009 🏛 Future Medicine 🌐 English ⚖ 731 KB

PMS48 Cost-Utility of Denosumab for the

✍ J. Darba; L. Kaskens; F. Sorio 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB